$Sarepta Therapeutics(SRPT.US$ SO THIS IS WHY ? Last quarter they raised the 2021 guidance to 605-615M and the slide in the presentation shows 612M unaudited annual revenue. $2.1B in cash. There is absolutely no reason the stock to sell off 12%, it is exactly what they guided , this is absolutely the best buying opportunity in the biotech sector period. Sarepta should be trading at $15B not pathetic 6.5B !
2021 Guidance Raised
Sarepta raised its guidance for revenue...
2021 Guidance Raised
Sarepta raised its guidance for revenue...
![Sarepta is way UNDERVALUED](https://ussnsimg.moomoo.com/moo-1641850277-70671410-iPhone-1-org.jpg/thumb)
$Lumentum(LITE.US$ 昨天有人注意到音量嗎?
已翻譯
$Onconova Therapeutics Inc(ONTX.US$ email to CEO to RESIGN SFRUCHTMAN@ONCONOVA.US ir@onconova.us this pattern of investors dilution has to STOP 🛑
$Onconova Therapeutics Inc(ONTX.US$ 發送電子郵件首席執行官 SFRUCHTMAN@ONCONOVA.US 辭職。我們需要新的管理層。
已翻譯
1
$Onconova Therapeutics Inc(ONTX.US$ 這家公司的市值太低,它是由詹姆斯·馬里諾(James Marino)經營,他將 Celtex 從 34 美分從 34 美分降到 50 美元,它將與 Onconova 做同樣。萬億美元以 2 億美元的價格售出! $Biocept Inc(BIOC.US$ 目前是另一個頂級收購候選人,微型股
已翻譯
1
已翻譯
4